Status:
COMPLETED
Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.
Lead Sponsor:
AUVA
Collaborating Sponsors:
Paracelsus Medical University
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2
SARS-CoV 2
Eligibility:
All Genders
15-90 years
Brief Summary
Context: On March 11, the World Health Organization (WHO) announced the current corona virus disease 2019 (COVID-19) outbreak as a pandemic. The first laboratory-confirmed case of COVID-19 in Austria ...
Eligibility Criteria
Inclusion
- employees in Austrian trauma hospitals and rehabilitation facilities of the Austrian Social Insurance for Occupational Risks (AUVA)
Exclusion
- NA
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 28 2020
Estimated Enrollment :
3301 Patients enrolled
Trial Details
Trial ID
NCT04354779
Start Date
May 11 2020
End Date
September 28 2020
Last Update
September 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allgemeine Unfallversicherungsanstalt
Vienna, Austria, 1200